25 XP   0   0   10

Enzo Biochem Inc
Buy, Hold or Sell?

Let's analyse Enzo together

PenkeI guess you are interested in Enzo Biochem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Enzo Biochem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Enzo Biochem Inc

I send you an email if I find something interesting about Enzo Biochem Inc.

Quick analysis of Enzo (30 sec.)










What can you expect buying and holding a share of Enzo? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.38
Expected worth in 1 year
$2.12
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$0.74
Return On Investment
68.0%

For what price can you sell your share?

Current Price per Share
$1.09
Expected price per share
$1 - $1.19
How sure are you?
50%

1. Valuation of Enzo (5 min.)




Live pricePrice per Share (EOD)

$1.09

Intrinsic Value Per Share

$-11.22 - $-3.65

Total Value Per Share

$-9.83 - $-2.26

2. Growth of Enzo (5 min.)




Is Enzo growing?

Current yearPrevious yearGrowGrow %
How rich?$70.7m$48.6m$13m21.1%

How much money is Enzo making?

Current yearPrevious yearGrowGrow %
Making money$14.9m-$7.6m$22.6m150.9%
Net Profit Margin-88.5%-39.9%--

How much money comes from the company's main activities?

3. Financial Health of Enzo (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#76 / 146

Most Revenue
#105 / 146

Most Profit
#42 / 146

Most Efficient
#107 / 146

What can you expect buying and holding a share of Enzo? (5 min.)

Welcome investor! Enzo's management wants to use your money to grow the business. In return you get a share of Enzo.

What can you expect buying and holding a share of Enzo?

First you should know what it really means to hold a share of Enzo. And how you can make/lose money.

Speculation

The Price per Share of Enzo is $1.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Enzo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Enzo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.38. Based on the TTM, the Book Value Change Per Share is $0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Enzo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-5.5%-0.15-14.1%-0.17-16.0%-0.08-6.9%-0.03-2.9%
Usd Book Value Change Per Share-0.15-13.8%0.1917.0%-0.16-14.5%0.000.3%0.021.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.15-13.8%0.1917.0%-0.16-14.5%0.000.3%0.021.7%
Usd Price Per Share1.26-1.65-2.10-2.55-4.05-
Price to Earnings Ratio-5.27--3.22--3.56-1.63--18.55-
Price-to-Total Gains Ratio-8.40--5.48--19.34--6.16-40.73-
Price to Book Ratio0.91-2.40-2.21-2.26-3.37-
Price-to-Total Gains Ratio-8.40--5.48--19.34--6.16-40.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.09
Number of shares917
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.190.00
Usd Total Gains Per Share0.190.00
Gains per Quarter (917 shares)169.812.93
Gains per Year (917 shares)679.2611.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106796690122
201359134802314
302038202703526
402717270604738
503396338505950
604076406407062
704755474308274
805434542209486
9061136101010698
100679367800117110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%10.030.00.025.0%51.087.00.037.0%
Book Value Change Per Share1.02.01.025.0%3.08.01.025.0%6.013.01.030.0%14.025.01.035.0%61.075.02.044.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%3.00.0135.02.2%
Total Gains per Share1.02.01.025.0%3.08.01.025.0%6.013.01.030.0%14.025.01.035.0%61.075.02.044.2%

Fundamentals of Enzo

About Enzo Biochem Inc

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Fundamental data was last updated by Penke on 2024-04-13 13:17:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Enzo Biochem Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Enzo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -35.8% means that $-0.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Enzo Biochem Inc:

  • The MRQ is -35.8%. The company is making a huge loss. -2
  • The TTM is -88.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-35.8%TTM-88.5%+52.7%
TTM-88.5%YOY-39.9%-48.6%
TTM-88.5%5Y-28.4%-60.1%
5Y-28.4%10Y-13.6%-14.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.8%-8.1%-27.7%
TTM-88.5%-7.5%-81.0%
YOY-39.9%0.3%-40.2%
5Y-28.4%-2.2%-26.2%
10Y-13.6%-2.5%-11.1%
1.1.2. Return on Assets

Shows how efficient Enzo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • -3.1% Return on Assets means that Enzo generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Enzo Biochem Inc:

  • The MRQ is -3.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 10.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM10.1%-13.1%
TTM10.1%YOY-8.9%+18.9%
TTM10.1%5Y-0.1%+10.2%
5Y-0.1%10Y0.1%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-1.7%-1.4%
TTM10.1%-1.4%+11.5%
YOY-8.9%-1.2%-7.7%
5Y-0.1%-0.6%+0.5%
10Y0.1%-0.9%+1.0%
1.1.3. Return on Equity

Shows how efficient Enzo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • -4.3% Return on Equity means Enzo generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Enzo Biochem Inc:

  • The MRQ is -4.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 4.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-4.3%TTM4.2%-8.6%
TTM4.2%YOY-17.9%+22.1%
TTM4.2%5Y-3.7%+7.9%
5Y-3.7%10Y-1.8%-1.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.3%-0.8%-3.5%
TTM4.2%-0.2%+4.4%
YOY-17.9%-0.2%-17.7%
5Y-3.7%-1.5%-2.2%
10Y-1.8%-2.5%+0.7%

1.2. Operating Efficiency of Enzo Biochem Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Enzo is operating .

  • Measures how much profit Enzo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • An Operating Margin of -16.6% means the company generated $-0.17  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Enzo Biochem Inc:

  • The MRQ is -16.6%. The company is operating very inefficient. -2
  • The TTM is -37.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-37.1%+20.5%
TTM-37.1%YOY-47.6%+10.5%
TTM-37.1%5Y-17.5%-19.6%
5Y-17.5%10Y-2.6%-15.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%-8.8%-7.8%
TTM-37.1%-0.7%-36.4%
YOY-47.6%4.0%-51.6%
5Y-17.5%2.1%-19.6%
10Y-2.6%-2.0%-0.6%
1.2.2. Operating Ratio

Measures how efficient Enzo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are $1.17 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Enzo Biochem Inc:

  • The MRQ is 1.166. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.647. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ1.166TTM0.647+0.520
TTM0.647YOY1.493-0.847
TTM0.6475Y1.113-0.466
5Y1.11310Y1.091+0.022
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1661.315-0.149
TTM0.6471.320-0.673
YOY1.4931.240+0.253
5Y1.1131.275-0.162
10Y1.0911.235-0.144

1.3. Liquidity of Enzo Biochem Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Enzo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.20 means the company has $3.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Enzo Biochem Inc:

  • The MRQ is 3.201. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.221. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.201TTM2.221+0.980
TTM2.221YOY1.926+0.295
TTM2.2215Y2.653-0.432
5Y2.65310Y3.000-0.347
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2012.194+1.007
TTM2.2212.366-0.145
YOY1.9262.753-0.827
5Y2.6533.035-0.382
10Y3.0003.068-0.068
1.3.2. Quick Ratio

Measures if Enzo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.78 means the company can pay off $2.78 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Enzo Biochem Inc:

  • The MRQ is 2.783. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.859. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.783TTM1.859+0.924
TTM1.859YOY1.139+0.720
TTM1.8595Y2.331-0.473
5Y2.33110Y2.604-0.272
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7831.272+1.511
TTM1.8591.346+0.513
YOY1.1391.564-0.425
5Y2.3311.933+0.398
10Y2.6042.129+0.475

1.4. Solvency of Enzo Biochem Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Enzo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Enzo to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.29 means that Enzo assets are financed with 28.6% credit (debt) and the remaining percentage (100% - 28.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Enzo Biochem Inc:

  • The MRQ is 0.286. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.434. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.434-0.148
TTM0.434YOY0.469-0.035
TTM0.4345Y0.412+0.022
5Y0.41210Y0.345+0.067
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.416-0.130
TTM0.4340.403+0.031
YOY0.4690.393+0.076
5Y0.4120.450-0.038
10Y0.3450.446-0.101
1.4.2. Debt to Equity Ratio

Measures if Enzo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Enzo to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 40.0% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Enzo Biochem Inc:

  • The MRQ is 0.400. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.078. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.400TTM1.078-0.679
TTM1.078YOY0.913+0.165
TTM1.0785Y0.795+0.283
5Y0.79510Y0.605+0.190
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4000.606-0.206
TTM1.0780.563+0.515
YOY0.9130.617+0.296
5Y0.7950.637+0.158
10Y0.6050.705-0.100

2. Market Valuation of Enzo Biochem Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Enzo generates.

  • Above 15 is considered overpriced but always compare Enzo to the Diagnostics & Research industry mean.
  • A PE ratio of -5.27 means the investor is paying $-5.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Enzo Biochem Inc:

  • The EOD is -4.560. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.272. Based on the earnings, the company is expensive. -2
  • The TTM is -3.216. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.560MRQ-5.272+0.711
MRQ-5.272TTM-3.216-2.056
TTM-3.216YOY-3.556+0.340
TTM-3.2165Y1.627-4.843
5Y1.62710Y-18.546+20.174
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.560-0.268-4.292
MRQ-5.272-0.439-4.833
TTM-3.216-0.368-2.848
YOY-3.556-0.003-3.553
5Y1.6274.755-3.128
10Y-18.5464.908-23.454
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Enzo Biochem Inc:

  • The EOD is -1.557. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.800. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.379. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.557MRQ-1.800+0.243
MRQ-1.800TTM-2.379+0.579
TTM-2.379YOY-6.938+4.559
TTM-2.3795Y-5.584+3.205
5Y-5.58410Y10.897-16.481
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.557-0.284-1.273
MRQ-1.800-0.534-1.266
TTM-2.379-1.432-0.947
YOY-6.938-2.547-4.391
5Y-5.584-1.847-3.737
10Y10.897-2.293+13.190
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Enzo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.91 means the investor is paying $0.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Enzo Biochem Inc:

  • The EOD is 0.789. Based on the equity, the company is cheap. +2
  • The MRQ is 0.912. Based on the equity, the company is cheap. +2
  • The TTM is 2.400. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.789MRQ0.912-0.123
MRQ0.912TTM2.400-1.488
TTM2.400YOY2.214+0.186
TTM2.4005Y2.257+0.143
5Y2.25710Y3.370-1.113
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.7891.771-0.982
MRQ0.9122.231-1.319
TTM2.4002.222+0.178
YOY2.2143.239-1.025
5Y2.2573.450-1.193
10Y3.3704.040-0.670
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Enzo Biochem Inc.

3.1. Institutions holding Enzo Biochem Inc

Institutions are holding 39.565% of the shares of Enzo Biochem Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Harbert Fund Advisors Inc10.10414.9312517591300
2023-12-31Renaissance Technologies Corp4.83970.00532479195-76869-3.0073
2023-09-30TANG CAPITAL MANAGEMENT LLC4.29470.43462200000-100000-4.3478
2023-12-31Vanguard Group Inc3.66340.000118766221475388.5327
2023-12-31Potomac Capital Management, Inc.2.89262.39441481742267421.8379
2023-12-31BlackRock Inc1.86170953667-1727-0.1808
2023-12-31Dimensional Fund Advisors, Inc.1.42440.0003729682-113404-13.4511
2023-12-31Geode Capital Management, LLC0.65950.000133785600
2023-12-31RBF LLC0.48870.021125035900
2023-12-31Anson Funds Management LP0.45110.03972310942310940
2023-12-31Bridgeway Capital Management, LLC0.44330.006822710000
2023-12-31State Street Corporation0.3261016703900
2023-12-31Northern Trust Corp0.2212011332691458.778
2023-12-31FNY Investment Advisers, LLC0.14820.116575911759110
2023-12-31Morgan Stanley - Brokerage Accounts0.14790757551160.1534
2023-12-31Assenagon Asset Management SA0.14140.000372416-8781-10.8144
2023-12-31Wittenberg Investment Management Inc0.13280.032868003680030
2023-12-31Lazard Asset Management LLC0.09850.00015045300
2023-12-31T. Rowe Price Associates, Inc.0.087504480000
2023-12-31Bank of New York Mellon Corp0.051202621700
Total 32.4787.983316637150+257768+1.5%

3.2. Funds holding Enzo Biochem Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.3190.0001118790800
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.20810.000861888100
2023-12-31Bridgeway Ultra-Small Company Market0.43240.165722150000
2024-02-29Fidelity Extended Market Index0.38880.0007199153-965-0.4822
2024-02-29DFA US Core Equity 2 I0.30140.000615437200
2024-03-29Dimensional US Targeted Value ETF0.28740.001914723800
2024-02-29DFA US Core Equity 1 I0.21080.000410798600
2024-03-28iShares Micro-Cap ETF0.18890.01349678000
2023-09-30BlackRock Extended Mkt Composite0.17520.00098972700
2024-03-31BlackRock Extended Equity Market K0.15290.000778308280.0358
2024-03-29Dimensional US Core Equity 2 ETF0.11450.00035863100
2024-02-29Fidelity Total Market Index0.10890.00015577500
2024-02-29Fidelity Series Total Market Index0.10220.00015236900
2023-12-31T. Rowe Price U.S. Equities Tr0.08750.00074480000
2024-03-31BlackRock U.S. Equity Market F0.08710.0003446014310.9758
2023-12-31Northern Trust Extended Eq Market Idx0.08440.001432381102934.242
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08440.001432381102934.242
2024-02-29DFA US Micro Cap I0.07860.00084024200
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.07130.000236523-1004385-96.4912
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.07130.00023652300
Total 6.55510.18993357793-982833-29.3%

3.3. Insider Transactions

Insiders are holding 24.193% of the shares of Enzo Biochem Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-02-13James G WolfBUY50001.28
2023-02-10James G WolfBUY50001.29
2023-01-27James G WolfBUY118001.4
2022-11-23Hamid ErfanianBUY1000001.97
2022-07-15Kara CannonBUY25002.42
2022-07-12Bradley Louis RadoffBUY125002.27
2022-07-05Bradley Louis RadoffBUY1200002.2
2022-06-15Bradley Louis RadoffBUY500002.21
2022-06-15Hamid ErfanianBUY46002.19
2022-06-14David BenchBUY35002.15

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Enzo Biochem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1500.185-181%-0.158+5%0.003-4790%0.019-897%
Book Value Per Share--1.3821.204+15%0.949+46%1.244+11%1.260+10%
Current Ratio--3.2012.221+44%1.926+66%2.653+21%3.000+7%
Debt To Asset Ratio--0.2860.434-34%0.469-39%0.412-31%0.345-17%
Debt To Equity Ratio--0.4001.078-63%0.913-56%0.795-50%0.605-34%
Dividend Per Share----0%-0%-0%-0%
Eps---0.060-0.154+157%-0.174+192%-0.075+26%-0.032-47%
Free Cash Flow Per Share---0.175-0.243+39%-0.134-23%-0.089-49%-0.035-80%
Free Cash Flow To Equity Per Share---0.175-0.251+43%-0.136-23%-0.085-52%-0.025-86%
Gross Profit Margin--1.0001.131-12%0.425+135%1.061-6%1.030-3%
Intrinsic Value_10Y_max---3.645--------
Intrinsic Value_10Y_min---11.215--------
Intrinsic Value_1Y_max---0.172--------
Intrinsic Value_1Y_min---0.667--------
Intrinsic Value_3Y_max---0.663--------
Intrinsic Value_3Y_min---2.411--------
Intrinsic Value_5Y_max---1.333--------
Intrinsic Value_5Y_min---4.588--------
Market Cap55836013.000-16%64544382.00084650469.250-24%107573970.000-40%130856050.650-51%207220762.925-69%
Net Profit Margin---0.358-0.885+147%-0.399+12%-0.284-21%-0.136-62%
Operating Margin---0.166-0.371+123%-0.476+186%-0.175+5%-0.026-85%
Operating Ratio--1.1660.647+80%1.493-22%1.113+5%1.091+7%
Pb Ratio0.789-16%0.9122.400-62%2.214-59%2.257-60%3.370-73%
Pe Ratio-4.560+13%-5.272-3.216-39%-3.556-33%1.627-424%-18.546+252%
Price Per Share1.090-16%1.2601.653-24%2.100-40%2.555-51%4.045-69%
Price To Free Cash Flow Ratio-1.557+13%-1.800-2.379+32%-6.938+285%-5.584+210%10.897-117%
Price To Total Gains Ratio-7.264+13%-8.397-5.482-35%-19.345+130%-6.165-27%40.733-121%
Quick Ratio--2.7831.859+50%1.139+144%2.331+19%2.604+7%
Return On Assets---0.0310.101-131%-0.089+187%-0.001-97%0.001-4517%
Return On Equity---0.0430.042-202%-0.179+314%-0.037-14%-0.018-58%
Total Gains Per Share---0.1500.185-181%-0.158+5%0.003-4790%0.019-897%
Usd Book Value--70775000.00061656750.000+15%48617250.000+46%63713400.000+11%64560625.000+10%
Usd Book Value Change Per Share---0.1500.185-181%-0.158+5%0.003-4790%0.019-897%
Usd Book Value Per Share--1.3821.204+15%0.949+46%1.244+11%1.260+10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.060-0.154+157%-0.174+192%-0.075+26%-0.032-47%
Usd Free Cash Flow---8963000.000-12472750.000+39%-6888500.000-23%-4562500.000-49%-1773450.000-80%
Usd Free Cash Flow Per Share---0.175-0.243+39%-0.134-23%-0.089-49%-0.035-80%
Usd Free Cash Flow To Equity Per Share---0.175-0.251+43%-0.136-23%-0.085-52%-0.025-86%
Usd Market Cap55836013.000-16%64544382.00084650469.250-24%107573970.000-40%130856050.650-51%207220762.925-69%
Usd Price Per Share1.090-16%1.2601.653-24%2.100-40%2.555-51%4.045-69%
Usd Profit---3061000.00014982000.000-120%-7622750.000+149%1034800.000-396%821475.000-473%
Usd Revenue--8553000.0009015250.000-5%20280000.000-58%20604050.000-58%22861075.000-63%
Usd Total Gains Per Share---0.1500.185-181%-0.158+5%0.003-4790%0.019-897%
 EOD+3 -5MRQTTM+19 -15YOY+24 -105Y+13 -2110Y+10 -24

4.2. Fundamental Score

Let's check the fundamental score of Enzo Biochem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.560
Price to Book Ratio (EOD)Between0-10.789
Net Profit Margin (MRQ)Greater than0-0.358
Operating Margin (MRQ)Greater than0-0.166
Quick Ratio (MRQ)Greater than12.783
Current Ratio (MRQ)Greater than13.201
Debt to Asset Ratio (MRQ)Less than10.286
Debt to Equity Ratio (MRQ)Less than10.400
Return on Equity (MRQ)Greater than0.15-0.043
Return on Assets (MRQ)Greater than0.05-0.031
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Enzo Biochem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.679
Ma 20Greater thanMa 501.213
Ma 50Greater thanMa 1001.274
Ma 100Greater thanMa 2001.298
OpenGreater thanClose1.110
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-01-31. Currency in USD. All numbers in thousands.

Summary
Total Assets99,077
Total Liabilities28,302
Total Stockholder Equity70,775
 As reported
Total Liabilities 28,302
Total Stockholder Equity+ 70,775
Total Assets = 99,077

Assets

Total Assets99,077
Total Current Assets80,920
Long-term Assets18,157
Total Current Assets
Cash And Cash Equivalents 65,241
Net Receivables 5,116
Inventory 7,800
Other Current Assets 2,763
Total Current Assets  (as reported)80,920
Total Current Assets  (calculated)80,920
+/-0
Long-term Assets
Property Plant Equipment 16,024
Long-term Assets Other 2,133
Long-term Assets  (as reported)18,157
Long-term Assets  (calculated)18,157
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,283
Long-term Liabilities3,019
Total Stockholder Equity70,775
Total Current Liabilities
Short-term Debt 4,162
Short Long Term Debt 3,300
Accounts payable 1,318
Other Current Liabilities 19,803
Total Current Liabilities  (as reported)25,283
Total Current Liabilities  (calculated)28,583
+/- 3,300
Long-term Liabilities
Capital Lease Obligations 3,647
Long-term Liabilities  (as reported)3,019
Long-term Liabilities  (calculated)3,647
+/- 628
Total Stockholder Equity
Common Stock504
Retained Earnings -278,027
Accumulated Other Comprehensive Income 2,046
Other Stockholders Equity 346,252
Total Stockholder Equity (as reported)70,775
Total Stockholder Equity (calculated)70,775
+/-0
Other
Capital Stock504
Cash and Short Term Investments 65,241
Common Stock Shares Outstanding 50,490
Liabilities and Stockholders Equity 99,077
Net Debt -58,060
Net Invested Capital 74,309
Net Working Capital 55,637
Property Plant and Equipment Gross 16,024
Short Long Term Debt Total 7,181



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-311995-07-311995-04-301995-01-311994-10-311994-07-311994-04-301994-01-311993-10-311993-07-311993-04-301993-01-311992-10-311992-07-311992-04-301992-01-311991-10-311991-07-311991-04-301991-01-311990-10-311990-07-311990-04-301990-01-311989-10-311989-07-311989-04-301989-01-311988-10-311988-07-311988-04-301988-01-311987-10-311987-07-311987-04-301987-01-311986-10-311986-07-311986-04-301986-01-311985-10-31
> Total Assets 
0
0
0
75,300
0
0
0
75,700
0
0
0
69,900
0
0
0
74,600
72,600
71,500
68,800
66,500
65,000
66,500
64,500
49,300
49,000
47,500
48,100
49,800
50,000
50,200
50,500
47,600
55,200
52,800
54,900
65,000
85,100
82,700
83,900
72,500
72,500
74,400
74,800
62,800
64,200
64,600
65,900
67,400
67,300
68,600
69,300
72,200
72,700
73,900
75,400
78,900
81,800
84,800
87,598
92,285
93,639
95,524
97,692
102,931
104,303
106,378
109,127
109,291
113,424
115,334
116,661
115,878
115,545
113,592
113,422
110,334
122,894
118,036
116,116
116,466
111,630
107,341
106,357
101,524
102,715
141,455
154,458
159,002
157,384
151,246
150,814
154,522
146,505
139,829
137,585
137,585
131,760
127,099
116,488
115,245
115,450
111,455
110,275
109,474
103,954
98,758
95,523
69,123
67,005
62,226
57,628
58,958
58,286
55,734
62,516
64,411
62,619
59,543
58,516
68,394
74,396
80,906
76,488
111,821
110,471
106,391
106,577
107,665
109,256
108,325
105,451
101,660
94,183
89,120
111,000
106,640
125,236
116,782
116,348
112,538
113,503
112,031
113,623
113,691
108,139
108,822
103,904
95,857
85,199
76,452
72,061
121,880
121,880
99,077
99,077121,880121,88072,06176,45285,19995,857103,904108,822108,139113,691113,623112,031113,503112,538116,348116,782125,236106,640111,00089,12094,183101,660105,451108,325109,256107,665106,577106,391110,471111,82176,48880,90674,39668,39458,51659,54362,61964,41162,51655,73458,28658,95857,62862,22667,00569,12395,52398,758103,954109,474110,275111,455115,450115,245116,488127,099131,760137,585137,585139,829146,505154,522150,814151,246157,384159,002154,458141,455102,715101,524106,357107,341111,630116,466116,116118,036122,894110,334113,422113,592115,545115,878116,661115,334113,424109,291109,127106,378104,303102,93197,69295,52493,63992,28587,59884,80081,80078,90075,40073,90072,70072,20069,30068,60067,30067,40065,90064,60064,20062,80074,80074,40072,50072,50083,90082,70085,10065,00054,90052,80055,20047,60050,50050,20050,00049,80048,10047,50049,00049,30064,50066,50065,00066,50068,80071,50072,60074,60000069,90000075,70000075,300000
   > Total Current Assets 
0
0
0
56,400
0
0
0
54,800
0
0
0
46,900
0
0
0
36,700
34,900
33,000
30,100
16,200
13,700
11,500
9,300
9,700
8,800
9,100
9,400
9,400
9,700
9,800
10,000
7,900
15,500
13,500
15,400
25,700
33,200
30,600
31,900
30,300
35,300
37,300
37,700
35,900
42,400
42,700
43,900
45,600
50,400
52,100
53,000
55,400
56,000
57,600
59,100
61,700
64,600
67,900
70,847
77,117
78,579
80,603
82,982
88,441
90,094
92,364
95,495
95,830
100,161
102,274
103,667
102,899
102,691
101,119
100,801
97,684
110,509
105,687
104,148
104,800
100,049
95,290
94,282
86,098
87,247
126,127
137,928
128,291
126,370
119,947
118,597
105,680
99,747
93,585
80,047
80,047
72,428
68,708
58,732
57,738
57,878
54,376
53,066
51,399
47,601
43,774
40,872
40,368
38,177
34,117
30,353
32,556
32,390
30,641
38,199
40,736
39,748
37,017
36,065
46,486
52,767
59,154
55,157
91,397
90,438
86,879
87,462
89,084
90,983
89,539
86,416
83,200
75,508
63,640
85,723
81,453
77,294
71,100
72,300
68,765
70,302
69,883
71,341
70,582
65,912
66,710
62,299
54,354
44,579
36,381
31,999
98,456
98,456
80,920
80,92098,45698,45631,99936,38144,57954,35462,29966,71065,91270,58271,34169,88370,30268,76572,30071,10077,29481,45385,72363,64075,50883,20086,41689,53990,98389,08487,46286,87990,43891,39755,15759,15452,76746,48636,06537,01739,74840,73638,19930,64132,39032,55630,35334,11738,17740,36840,87243,77447,60151,39953,06654,37657,87857,73858,73268,70872,42880,04780,04793,58599,747105,680118,597119,947126,370128,291137,928126,12787,24786,09894,28295,290100,049104,800104,148105,687110,50997,684100,801101,119102,691102,899103,667102,274100,16195,83095,49592,36490,09488,44182,98280,60378,57977,11770,84767,90064,60061,70059,10057,60056,00055,40053,00052,10050,40045,60043,90042,70042,40035,90037,70037,30035,30030,30031,90030,60033,20025,70015,40013,50015,5007,90010,0009,8009,7009,4009,4009,1008,8009,7009,30011,50013,70016,20030,10033,00034,90036,70000046,90000054,80000056,400000
       Cash And Cash Equivalents 
0
0
0
53,000
0
0
0
50,300
0
0
0
43,800
0
0
0
29,800
27,400
24,600
21,700
7,200
4,100
1,900
300
600
200
300
400
800
800
1,000
1,100
700
7,100
4,800
5,000
4,200
15,600
12,300
11,700
11,100
15,500
16,400
16,000
17,800
23,500
23,200
23,700
25,300
30,000
31,000
32,000
33,500
39,200
40,200
41,900
43,200
44,300
46,500
47,660
51,027
53,536
54,387
56,484
58,671
61,215
61,883
63,542
67,135
73,248
75,935
79,116
63,268
63,446
59,806
59,879
54,499
68,619
69,123
73,593
76,981
75,242
76,362
75,912
69,854
71,960
110,916
120,024
105,149
103,786
98,553
96,503
78,322
36,826
8,480
7,554
7,554
6,074
8,157
8,597
8,759
8,752
8,989
9,709
14,161
11,377
8,589
5,247
15,076
13,401
10,023
5,644
9,007
7,426
7,621
14,804
17,455
16,591
15,346
14,375
18,109
30,642
37,016
32,360
67,777
67,214
62,427
62,627
64,167
66,849
64,468
62,556
60,041
52,777
41,978
64,052
60,146
56,893
51,502
54,407
47,865
45,914
44,536
44,271
13,524
6,356
4,159
31,130
21,603
12,135
5,054
2,632
82,373
82,373
65,241
65,24182,37382,3732,6325,05412,13521,60331,1304,1596,35613,52444,27144,53645,91447,86554,40751,50256,89360,14664,05241,97852,77760,04162,55664,46866,84964,16762,62762,42767,21467,77732,36037,01630,64218,10914,37515,34616,59117,45514,8047,6217,4269,0075,64410,02313,40115,0765,2478,58911,37714,1619,7098,9898,7528,7598,5978,1576,0747,5547,5548,48036,82678,32296,50398,553103,786105,149120,024110,91671,96069,85475,91276,36275,24276,98173,59369,12368,61954,49959,87959,80663,44663,26879,11675,93573,24867,13563,54261,88361,21558,67156,48454,38753,53651,02747,66046,50044,30043,20041,90040,20039,20033,50032,00031,00030,00025,30023,70023,20023,50017,80016,00016,40015,50011,10011,70012,30015,6004,2005,0004,8007,1007001,1001,0008008004003002006003001,9004,1007,20021,70024,60027,40029,80000043,80000050,30000053,000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,154
15,179
15,310
15,341
17,242
18,296
12,449
6,680
6,714
6,168
0
0
0
0
0
0
0
0
0
0
0
39,748
64,452
47,704
47,704
40,308
36,309
25,805
24,807
22,807
21,808
17,808
10,000
10,000
10,000
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,932
29,978
29,810
29,480
0
0
0
0
0
0
0
0
0000000029,48029,81029,97829,9320000000000000000000000000000000000010,00010,00010,00010,00017,80821,80822,80724,80725,80536,30940,30847,70447,70464,45239,748000000000006,1686,7146,68012,44918,29617,24215,34115,31015,17915,15400000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
600
0
0
0
1,600
0
0
0
1,800
0
0
0
4,800
4,900
5,500
5,800
5,800
6,700
6,900
6,500
6,700
6,500
6,500
6,800
6,400
6,800
6,400
6,600
5,000
5,900
6,100
7,300
15,800
9,900
10,500
12,200
10,900
11,900
12,600
13,700
10,500
14,900
15,400
16,500
17,000
17,600
18,100
18,500
19,100
14,000
14,700
14,500
15,000
17,100
17,500
19,492
20,211
19,788
20,809
22,782
24,559
24,142
23,651
25,491
20,268
21,051
20,115
17,888
17,266
16,643
17,072
17,881
18,701
17,350
18,055
18,239
13,421
12,114
11,652
14,073
12,378
11,899
12,056
15,044
14,353
14,534
13,493
14,123
15,348
12,688
11,053
12,358
12,358
13,699
12,006
12,038
13,006
14,883
12,553
13,770
15,245
14,671
13,404
13,891
14,135
14,003
12,580
13,188
12,288
13,717
11,855
12,315
12,470
12,379
11,795
11,613
18,759
12,763
12,877
14,000
14,592
14,057
15,355
15,805
15,180
14,443
14,977
14,407
13,147
12,836
11,665
11,441
10,738
9,877
8,912
6,817
9,141
12,051
12,095
11,475
10,198
11,332
15,316
11,761
11,516
11,515
10,866
9,636
4,808
4,808
5,116
5,1164,8084,8089,63610,86611,51511,51611,76115,31611,33210,19811,47512,09512,0519,1416,8178,9129,87710,73811,44111,66512,83613,14714,40714,97714,44315,18015,80515,35514,05714,59214,00012,87712,76318,75911,61311,79512,37912,47012,31511,85513,71712,28813,18812,58014,00314,13513,89113,40414,67115,24513,77012,55314,88313,00612,03812,00613,69912,35812,35811,05312,68815,34814,12313,49314,53414,35315,04412,05611,89912,37814,07311,65212,11413,42118,23918,05517,35018,70117,88117,07216,64317,26617,88820,11521,05120,26825,49123,65124,14224,55922,78220,80919,78820,21119,49217,50017,10015,00014,50014,70014,00019,10018,50018,10017,60017,00016,50015,40014,90010,50013,70012,60011,90010,90012,20010,5009,90015,8007,3006,1005,9005,0006,6006,4006,8006,4006,8006,5006,5006,7006,5006,9006,7005,8005,8005,5004,9004,8000001,8000001,600000600000
       Other Current Assets 
0
0
0
1,400
0
0
0
2,200
0
0
0
400
0
0
0
1,000
1,500
1,700
1,400
1,100
1,400
1,200
1,000
900
600
800
700
600
500
800
600
500
800
800
1,100
3,600
5,500
5,600
5,700
6,100
5,700
5,900
5,800
5,800
2,300
2,300
2,000
1,700
1,200
1,300
1,000
1,400
1,500
1,400
1,300
2,100
1,700
2,200
2,123
4,080
3,506
3,601
1,077
1,132
984
1,802
1,433
1,491
80
2,564
2,448
3,789
4,101
795
4,653
3,807
2,936
2,776
303
4,809
1,874
2,533
1,517
1,465
1,024
772
739
1,767
1,637
1,633
1,510
2,496
1,762
1,491
1,973
1,973
2,661
2,188
2,101
2,284
2,069
2,024
2,082
2,733
2,329
2,390
2,338
2,357
2,102
2,214
2,250
2,456
2,140
1,945
2,104
2,121
2,255
1,593
2,099
2,222
1,780
1,866
1,819
2,057
1,919
1,982
1,860
2,690
2,481
2,613
2,175
2,734
2,307
2,483
2,635
2,727
2,956
3,184
3,058
3,975
4,152
3,994
3,838
4,230
4,457
3,904
4,474
5,824
5,142
4,738
4,442
1,000
2,336
2,763
2,7632,3361,0004,4424,7385,1425,8244,4743,9044,4574,2303,8383,9944,1523,9753,0583,1842,9562,7272,6352,4832,3072,7342,1752,6132,4812,6901,8601,9821,9192,0571,8191,8661,7802,2222,0991,5932,2552,1212,1041,9452,1402,4562,2502,2142,1022,3572,3382,3902,3292,7332,0822,0242,0692,2842,1012,1882,6611,9731,9731,4911,7622,4961,5101,6331,6371,7677397721,0241,4651,5172,5331,8744,8093032,7762,9363,8074,6537954,1013,7892,4482,564801,4911,4331,8029841,1321,0773,6013,5064,0802,1232,2001,7002,1001,3001,4001,5001,4001,0001,3001,2001,7002,0002,3002,3005,8005,8005,9005,7006,1005,7005,6005,5003,6001,1008008005006008005006007008006009001,0001,2001,4001,1001,4001,7001,5001,0000004000002,2000001,400000
   > Long-term Assets 
0
0
0
18,900
0
0
0
20,900
0
0
0
23,000
0
0
0
37,900
37,700
38,500
38,700
50,300
51,300
55,000
55,200
39,600
40,200
38,400
38,700
40,400
40,300
40,400
40,500
39,700
39,700
39,300
39,500
39,300
51,900
52,100
52,000
42,200
37,200
37,100
37,100
26,900
21,800
21,900
22,000
21,800
16,900
16,500
16,300
16,800
16,700
16,300
16,300
17,200
17,200
16,900
16,751
15,169
15,060
14,921
14,710
14,490
14,209
14,014
13,632
13,462
13,263
13,060
12,994
12,979
12,854
12,473
12,621
12,651
12,385
12,349
11,968
11,666
11,581
12,051
12,075
15,426
15,468
15,328
16,530
30,711
31,014
31,299
32,217
48,842
46,758
46,244
0
57,538
59,332
58,391
57,756
57,507
57,572
57,079
57,209
58,075
56,353
54,984
54,651
28,755
28,828
28,109
27,275
26,402
25,896
25,093
24,317
23,675
22,871
22,526
22,451
21,908
21,629
21,752
21,331
20,424
20,033
19,512
19,115
18,581
18,273
18,786
19,035
18,460
18,675
25,480
25,277
25,187
47,942
45,682
44,048
43,773
43,201
42,148
42,282
43,109
42,227
42,112
41,605
41,503
40,620
40,071
40,062
23,424
23,424
18,157
18,15723,42423,42440,06240,07140,62041,50341,60542,11242,22743,10942,28242,14843,20143,77344,04845,68247,94225,18725,27725,48018,67518,46019,03518,78618,27318,58119,11519,51220,03320,42421,33121,75221,62921,90822,45122,52622,87123,67524,31725,09325,89626,40227,27528,10928,82828,75554,65154,98456,35358,07557,20957,07957,57257,50757,75658,39159,33257,538046,24446,75848,84232,21731,29931,01430,71116,53015,32815,46815,42612,07512,05111,58111,66611,96812,34912,38512,65112,62112,47312,85412,97912,99413,06013,26313,46213,63214,01414,20914,49014,71014,92115,06015,16916,75116,90017,20017,20016,30016,30016,70016,80016,30016,50016,90021,80022,00021,90021,80026,90037,10037,10037,20042,20052,00052,10051,90039,30039,50039,30039,70039,70040,50040,40040,30040,40038,70038,40040,20039,60055,20055,00051,30050,30038,70038,50037,70037,90000023,00000020,90000018,900000
       Property Plant Equipment 
0
0
0
4,600
0
0
0
6,100
0
0
0
7,300
0
0
0
11,500
12,100
13,300
14,800
19,200
22,300
26,800
27,300
23,200
23,800
23,300
23,300
23,700
23,700
24,000
24,100
23,200
23,300
23,500
23,800
23,600
23,800
24,000
24,000
13,900
13,700
13,600
13,500
3,100
3,000
2,900
2,900
2,900
2,900
2,600
2,500
2,600
2,700
2,500
2,600
2,800
3,000
2,900
2,803
2,801
2,838
2,867
2,723
2,671
2,561
2,477
2,315
2,301
2,250
2,198
2,177
2,200
2,242
2,237
2,332
2,415
2,454
2,747
2,681
2,670
2,603
3,093
3,127
5,848
5,755
5,669
6,181
6,621
6,695
6,971
7,191
9,053
9,351
9,562
11,012
11,012
11,824
12,069
11,927
11,858
11,668
11,290
10,908
10,335
9,776
9,415
9,184
9,116
9,505
9,252
8,928
8,617
8,510
8,112
7,807
7,730
7,480
7,567
7,955
7,948
8,132
8,730
8,638
8,214
8,276
8,168
8,093
7,901
7,837
7,945
7,953
7,636
7,503
13,925
14,244
14,254
37,146
35,581
34,107
34,398
33,822
32,922
33,036
33,605
33,212
32,934
32,507
32,433
31,559
30,994
30,963
16,712
16,712
16,024
16,02416,71216,71230,96330,99431,55932,43332,50732,93433,21233,60533,03632,92233,82234,39834,10735,58137,14614,25414,24413,9257,5037,6367,9537,9457,8377,9018,0938,1688,2768,2148,6388,7308,1327,9487,9557,5677,4807,7307,8078,1128,5108,6178,9289,2529,5059,1169,1849,4159,77610,33510,90811,29011,66811,85811,92712,06911,82411,01211,0129,5629,3519,0537,1916,9716,6956,6216,1815,6695,7555,8483,1273,0932,6032,6702,6812,7472,4542,4152,3322,2372,2422,2002,1772,1982,2502,3012,3152,4772,5612,6712,7232,8672,8382,8012,8032,9003,0002,8002,6002,5002,7002,6002,5002,6002,9002,9002,9002,9003,0003,10013,50013,60013,70013,90024,00024,00023,80023,60023,80023,50023,30023,20024,10024,00023,70023,70023,30023,30023,80023,20027,30026,80022,30019,20014,80013,30012,10011,5000007,3000006,1000004,600000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,915
7,823
7,730
7,637
7,544
7,452
7,452
7,452
7,452
3,166
7,452
7,452
7,452
7,451
7,452
7,452
7,452
7,451
7,452
7,452
7,452
7,452
7,452
7,452
7,452
13,676
13,908
13,908
14,270
21,321
20,404
20,076
26,253
26,253
25,166
24,740
24,773
24,943
25,235
25,361
25,819
27,373
26,912
26,580
26,684
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
0
0
0
0007,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,45226,68426,58026,91227,37325,81925,36125,23524,94324,77324,74025,16626,25326,25320,07620,40421,32114,27013,90813,90813,6767,4527,4527,4527,4527,4527,4527,4527,4517,4527,4527,4527,4517,4527,4527,4523,1667,4527,4527,4527,4527,5447,6377,7307,8237,91500000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,600
0
0
0
1,500
0
0
0
1,600
0
0
0
12,600
12,500
12,500
12,400
14,900
12,200
12,100
12,000
15,000
11,800
11,700
11,600
11,600
11,500
11,400
11,300
11,200
11,100
10,600
10,500
10,400
10,300
10,200
10,100
10,000
10,000
9,900
9,800
9,700
9,600
9,500
14,100
9,300
13,900
9,100
9,000
8,900
8,800
8,700
8,700
8,600
8,500
8,400
8,285
8,193
8,100
8,008
3,935
3,865
3,784
3,770
7,544
3,562
3,414
3,262
7,452
7,452
7,452
7,452
7,452
7,452
9,768
9,437
9,122
8,785
8,767
8,748
1,277
1,257
1,237
1,218
1,198
9,338
9,217
9,097
8,976
17,656
16,532
15,958
19,817
19,817
21,953
21,152
20,664
20,368
20,280
19,995
20,040
19,985
19,310
18,636
18,349
11,780
11,420
10,974
10,416
9,943
9,564
9,111
8,714
8,108
7,557
7,122
6,658
6,155
5,707
5,221
4,884
4,422
3,971
3,560
3,244
2,895
2,647
2,449
2,149
1,886
1,625
1,388
1,128
1,032
892
752
588
538
460
393
315
244
171
100
29
7,452
7,452
7,452
7,452
0
0
0
0007,4527,4527,4527,452291001712443153934605385887528921,0321,1281,3881,6251,8862,1492,4492,6472,8953,2443,5603,9714,4224,8845,2215,7076,1556,6587,1227,5578,1088,7149,1119,5649,94310,41610,97411,42011,78018,34918,63619,31019,98520,04019,99520,28020,36820,66421,15221,95319,81719,81715,95816,53217,6568,9769,0979,2179,3381,1981,2181,2371,2571,2778,7488,7678,7859,1229,4379,7687,4527,4527,4527,4527,4527,4523,2623,4143,5627,5443,7703,7843,8653,9358,0088,1008,1938,2858,4008,5008,6008,7008,7008,8008,9009,0009,10013,9009,30014,1009,5009,6009,7009,8009,90010,00010,00010,10010,20010,30010,40010,50010,60011,10011,20011,30011,40011,50011,60011,60011,70011,80015,00012,00012,10012,20014,90012,40012,50012,50012,6000001,6000001,5000001,600000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,025
13,948
12,368
12,222
12,054
11,987
11,820
11,648
11,537
11,317
11,160
11,013
10,862
10,817
10,779
10,612
10,236
10,289
10,235
9,931
9,602
9,287
8,996
8,978
8,958
8,948
9,578
9,713
9,659
10,349
24,090
24,319
24,328
25,026
39,789
37,407
36,682
46,526
47,344
47,508
46,322
45,829
45,649
45,904
45,789
46,301
47,740
46,577
45,569
45,467
19,639
19,323
18,857
18,347
17,785
17,386
16,981
16,510
15,945
15,391
14,959
14,496
13,960
13,497
13,022
12,693
12,210
11,757
11,344
11,022
10,680
10,436
10,841
1,481
1,486
2,095
2,715
2,453
2,449
2,452
1,897
1,901
1,385
1,467
1,381
1,479
1,808
1,392
1,626
1,617
1,618
1,609
1,625
1,647
6,712
1,816
0
01,8166,7121,6471,6251,6091,6181,6171,6261,3921,8081,4791,3811,4671,3851,9011,8972,4522,4492,4532,7152,0951,4861,48110,84110,43610,68011,02211,34411,75712,21012,69313,02213,49713,96014,49614,95915,39115,94516,51016,98117,38617,78518,34718,85719,32319,63945,46745,56946,57747,74046,30145,78945,90445,64945,82946,32247,50847,34446,52636,68237,40739,78925,02624,32824,31924,09010,3499,6599,7139,5788,9488,9588,9788,9969,2879,6029,93110,23510,28910,23610,61210,77910,81710,86211,01311,16011,31711,53711,64811,82011,98712,05412,22212,36813,94814,025000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
50,700
0
0
0
52,000
0
0
0
50,600
0
0
0
59,500
58,300
58,700
57,400
53,800
53,200
56,600
56,800
48,200
48,300
13,800
14,300
16,800
16,600
16,400
16,300
15,300
14,200
8,200
10,400
13,800
15,100
12,100
12,000
11,400
10,200
10,600
10,500
7,500
3,800
2,500
2,900
3,400
2,600
3,300
3,000
3,400
3,200
3,000
2,700
3,300
3,500
3,100
2,920
5,109
4,369
4,288
4,118
5,414
4,928
6,147
6,380
4,558
4,980
5,444
5,538
6,498
6,251
5,210
5,218
6,168
11,661
7,057
6,023
8,199
6,177
5,323
6,973
5,937
7,916
7,863
9,902
17,108
15,943
13,227
13,821
16,233
15,381
16,554
17,990
17,990
15,580
21,619
14,448
18,229
18,525
19,605
18,628
20,759
20,482
19,917
19,114
20,022
21,293
21,936
22,206
24,826
25,192
23,544
24,593
27,461
26,506
24,681
24,456
25,788
27,183
26,459
23,520
22,267
21,980
18,663
18,015
18,793
20,074
20,366
19,072
20,539
18,513
21,623
20,001
20,612
46,908
45,922
54,018
54,157
54,485
50,242
48,656
45,105
41,379
43,696
41,717
41,395
40,209
43,622
53,133
43,418
43,418
28,302
28,30243,41843,41853,13343,62240,20941,39541,71743,69641,37945,10548,65650,24254,48554,15754,01845,92246,90820,61220,00121,62318,51320,53919,07220,36620,07418,79318,01518,66321,98022,26723,52026,45927,18325,78824,45624,68126,50627,46124,59323,54425,19224,82622,20621,93621,29320,02219,11419,91720,48220,75918,62819,60518,52518,22914,44821,61915,58017,99017,99016,55415,38116,23313,82113,22715,94317,1089,9027,8637,9165,9376,9735,3236,1778,1996,0237,05711,6616,1685,2185,2106,2516,4985,5385,4444,9804,5586,3806,1474,9285,4144,1184,2884,3695,1092,9203,1003,5003,3002,7003,0003,2003,4003,0003,3002,6003,4002,9002,5003,8007,50010,50010,60010,20011,40012,00012,10015,10013,80010,4008,20014,20015,30016,30016,40016,60016,80014,30013,80048,30048,20056,80056,60053,20053,80057,40058,70058,30059,50000050,60000052,00000050,700000
   > Total Current Liabilities 
0
0
0
2,000
0
0
0
2,700
0
0
0
2,200
0
0
0
5,500
4,700
5,700
4,600
5,600
4,900
14,000
41,600
43,400
43,000
8,400
8,800
12,100
11,800
11,600
11,300
10,300
6,000
3,200
5,400
8,600
9,800
6,900
6,700
5,800
4,600
4,800
4,900
6,500
2,700
1,500
1,800
2,400
1,600
2,300
2,100
2,400
2,200
2,000
1,800
2,400
2,600
2,200
2,090
3,624
2,916
2,869
2,723
3,347
2,901
4,160
4,433
2,863
3,334
3,847
3,990
5,176
5,095
4,138
4,172
5,424
10,959
6,601
5,427
7,789
6,027
5,173
6,973
5,937
7,916
7,863
8,852
14,441
13,173
10,553
11,301
13,288
12,921
14,301
15,861
15,861
13,252
19,413
12,300
15,557
15,822
16,890
15,865
17,729
17,563
17,096
16,325
18,956
19,835
20,444
20,732
23,852
24,241
22,647
22,145
24,965
24,509
22,690
22,536
23,958
25,789
24,504
21,672
20,568
20,777
17,565
16,958
17,810
19,541
19,871
18,668
20,186
18,193
16,596
15,272
16,009
22,999
23,200
31,870
32,801
33,608
29,949
29,214
26,076
23,106
26,148
24,702
24,550
24,253
32,201
42,152
39,989
39,989
25,283
25,28339,98939,98942,15232,20124,25324,55024,70226,14823,10626,07629,21429,94933,60832,80131,87023,20022,99916,00915,27216,59618,19320,18618,66819,87119,54117,81016,95817,56520,77720,56821,67224,50425,78923,95822,53622,69024,50924,96522,14522,64724,24123,85220,73220,44419,83518,95616,32517,09617,56317,72915,86516,89015,82215,55712,30019,41313,25215,86115,86114,30112,92113,28811,30110,55313,17314,4418,8527,8637,9165,9376,9735,1736,0277,7895,4276,60110,9595,4244,1724,1385,0955,1763,9903,8473,3342,8634,4334,1602,9013,3472,7232,8692,9163,6242,0902,2002,6002,4001,8002,0002,2002,4002,1002,3001,6002,4001,8001,5002,7006,5004,9004,8004,6005,8006,7006,9009,8008,6005,4003,2006,00010,30011,30011,60011,80012,1008,8008,40043,00043,40041,60014,0004,9005,6004,6005,7004,7005,5000002,2000002,7000002,000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
200
200
200
200
200
32,200
32,200
32,300
4,900
5,200
1,900
1,800
2,000
1,600
1,900
1,400
300
2,300
2,200
200
100
100
100
100
100
100
100
100
100
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,308
2,143
3,023
4,866
0
0
150
0
6,134
0
6,233
9,043
8,115
5,492
6,576
7,828
8,063
9,374
0
9,145
0
0
0
0
0
0
0
0
9,387
0
0
0
0
281
313
3,595
3,994
3,255
3,374
3,403
3,391
3,443
3,464
3,013
3,013
3,581
2,555
1,557
2,000
0
1,047
122
89
60
37
23
0
0
0
136
4,852
4,759
4,482
11,465
10,966
10,746
10,514
3,652
3,448
3,267
3,252
3,742
3,536
7,187
10,938
2,514
3,569
4,162
4,1623,5692,51410,9387,1873,5363,7423,2523,2673,4483,65210,51410,74610,96611,4654,4824,7594,852136000233760891221,04702,0001,5572,5553,5813,0133,0133,4643,4433,3913,4033,3743,2553,9943,59531328100009,387000000009,14509,3748,0637,8286,5765,4928,1159,0436,23306,1340150004,8663,0232,1433,3080000000000000000000000000001001001001001001001001001001001001002002,2002,3003001,4001,9001,6002,0001,8001,9005,2004,90032,30032,20032,200200200200200200200200000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,726
0
0
0
3,586
0
0
2,000
2,456
2,000
0
1,047
122
89
60
37
23
0
0
0
136
138
149
0
7,144
7,000
7,000
7,000
152
0
0
0
229
0
3,684
7,175
2,589
2,917
3,300
3,3002,9172,5897,1753,68402290001527,0007,0007,0007,1440149138136000233760891221,04702,0002,4562,000003,5860003,7260000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
600
600
600
800
800
800
1,100
2,800
2,500
2,400
2,500
2,300
2,500
2,500
2,300
2,600
1,100
800
800
900
4,400
2,500
2,200
2,900
2,700
1,000
1,400
1,200
1,300
1,000
900
900
1,100
800
1,500
1,300
1,400
1,600
1,200
1,000
1,200
1,800
1,100
1,139
1,471
884
1,359
1,336
2,040
1,035
1,521
880
1,512
1,118
826
602
1,321
2,097
1,297
1,250
2,092
1,195
977
1,209
2,414
1,832
1,710
1,422
1,304
1,392
985
1,595
4,111
3,747
3,786
3,486
4,299
3,344
3,652
2,952
2,952
4,098
4,833
4,531
6,455
7,227
7,154
7,150
7,858
6,526
7,819
7,204
9,020
7,871
8,962
9,185
8,481
8,721
8,818
7,411
8,245
7,098
6,840
7,612
8,762
9,450
9,459
9,152
9,857
9,338
10,285
9,400
10,350
9,558
9,564
8,250
9,516
7,155
7,773
6,423
7,256
8,630
8,185
8,523
8,503
7,842
4,432
6,014
8,123
5,929
6,860
7,664
8,508
8,109
13,189
13,645
3,575
3,575
1,318
1,3183,5753,57513,64513,1898,1098,5087,6646,8605,9298,1236,0144,4327,8428,5038,5238,1858,6307,2566,4237,7737,1559,5168,2509,5649,55810,3509,40010,2859,3389,8579,1529,4599,4508,7627,6126,8407,0988,2457,4118,8188,7218,4819,1858,9627,8719,0207,2047,8196,5267,8587,1507,1547,2276,4554,5314,8334,0982,9522,9523,6523,3444,2993,4863,7863,7474,1111,5959851,3921,3041,4221,7101,8322,4141,2099771,1952,0921,2501,2972,0971,3216028261,1181,5128801,5211,0352,0401,3361,3598841,4711,1391,1001,8001,2001,0001,2001,6001,4001,3001,5008001,1009009001,0001,3001,2001,4001,0002,7002,9002,2002,5004,4009008008001,1002,6002,3002,5002,5002,3002,5002,4002,5002,8001,100800800800600600600000000000000000
       Other Current Liabilities 
0
0
0
2,000
0
0
0
2,700
0
0
0
2,200
0
0
0
4,700
3,900
4,900
3,600
4,600
3,900
12,700
6,600
8,700
8,300
1,000
1,300
7,700
7,500
7,300
7,100
7,300
3,800
2,100
2,200
2,000
7,100
4,600
3,700
3,000
3,500
3,300
3,600
5,100
1,600
500
800
1,200
700
800
800
1,000
600
800
800
1,200
800
1,100
951
2,154
2,032
1,510
1,387
1,308
1,866
2,639
3,553
1,350
2,216
3,021
3,388
3,855
2,998
2,841
2,922
3,332
4,456
1,978
240
150
4,195
3,463
5,401
4,633
150
6,878
254
517
481
445
409
72
1,124
1,005
12,909
3,610
9,154
14,580
7,769
9,102
8,595
9,736
8,715
9,871
1,303
9,277
9,121
9,936
11,964
11,201
11,234
11,776
11,526
10,574
11,360
13,317
14,020
12,407
11,460
886
969
11,464
9,965
943
926
7,280
7,558
7,460
9,983
10,307
10,418
10,670
11,038
8,823
8,849
8,753
138
149
16,339
10,307
12,274
12,245
10,272
11,626
11,630
15,340
13,786
12,300
12,608
11,825
75
21,102
21,102
19,803
19,80321,10221,1027511,82512,60812,30013,78615,34011,63011,62610,27212,24512,27410,30716,3391491388,7538,8498,82311,03810,67010,41810,3079,9837,4607,5587,2809269439,96511,46496988611,46012,40714,02013,31711,36010,57411,52611,77611,23411,20111,9649,9369,1219,2771,3039,8718,7159,7368,5959,1027,76914,5809,1543,61012,9091,0051,124724094454815172546,8781504,6335,4013,4634,1951502401,9784,4563,3322,9222,8412,9983,8553,3883,0212,2161,3503,5532,6391,8661,3081,3871,5102,0322,1549511,1008001,2008008006001,0008008007001,2008005001,6005,1003,6003,3003,5003,0003,7004,6007,1002,0002,2002,1003,8007,3007,1007,3007,5007,7001,3001,0008,3008,7006,60012,7003,9004,6003,6004,9003,9004,7000002,2000002,7000002,000000
   > Long-term Liabilities 
0
0
0
48,700
0
0
0
49,300
0
0
0
48,400
0
0
0
54,000
53,600
53,000
52,800
48,200
48,300
42,600
15,200
4,800
5,300
5,400
5,500
4,700
4,800
4,800
5,000
5,000
8,200
5,000
5,000
5,200
5,300
5,200
5,300
5,600
5,600
5,800
5,600
1,000
1,100
1,000
1,100
1,000
1,000
1,000
900
1,000
1,000
1,000
900
900
900
900
830
1,485
1,453
1,419
1,395
2,067
2,027
1,987
1,947
1,696
1,646
1,597
1,548
1,322
1,156
1,072
1,046
744
702
456
596
410
150
150
1,572
1,304
1,632
985
1,050
2,667
2,770
2,674
2,520
2,945
2,460
2,253
0
2,129
2,328
2,206
2,148
2,672
2,703
2,715
2,763
3,030
2,919
2,821
2,789
1,066
1,458
1,492
1,474
974
951
897
2,448
2,496
1,997
1,991
1,920
1,830
1,394
1,955
1,848
1,699
1,203
1,098
1,057
983
533
495
404
353
320
5,027
4,729
4,603
23,909
22,722
22,148
21,356
20,877
20,293
19,442
19,029
18,273
17,548
17,015
16,845
15,956
11,421
10,981
3,429
3,429
3,019
3,0193,4293,42910,98111,42115,95616,84517,01517,54818,27319,02919,44220,29320,87721,35622,14822,72223,9094,6034,7295,0273203534044955339831,0571,0981,2031,6991,8481,9551,3941,8301,9201,9911,9972,4962,4488979519741,4741,4921,4581,0662,7892,8212,9193,0302,7632,7152,7032,6722,1482,2062,3282,12902,2532,4602,9452,5202,6742,7702,6671,0509851,6321,3041,5721501504105964567027441,0461,0721,1561,3221,5481,5971,6461,6961,9471,9872,0272,0671,3951,4191,4531,4858309009009009001,0001,0001,0009001,0001,0001,0001,1001,0001,1001,0005,6005,8005,6005,6005,3005,2005,3005,2005,0005,0008,2005,0005,0004,8004,8004,7005,5005,4005,3004,80015,20042,60048,30048,20052,80053,00053,60054,00000048,40000049,30000048,700000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,464
4,235
4,179
4,527
4,138
4,509
4,485
4,447
4,428
4,390
4,466
4,314
4,270
4,177
4,077
3,986
289
247
269
0
0
002692472893,9864,0774,1774,2704,3144,4664,3904,4284,4474,4854,5094,1384,5274,1794,2354,4640000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
840
830
796
764
730
706
675
635
595
555
514
466
417
368
87
0
0
0
300
300
300
150
150
0
0
0
0
0
0
1,050
938
825
740
600
512
390
270
154
38
0
0
0
90
55
83
91
0
0
0
0
0
0
0
0
0
0
0
1,600
1,600
1,200
1,200
1,200
1,220
807
800
803
800
400
400
400
410
533
495
404
0
320
563
0
424
352
0
0
31
0
0
0
5
5
0
0
0
18
0
0
0
0
0
0000018000550003100352424056332004044955334104004004008008038008071,2201,2001,2001,2001,6001,6000000000000091835590000381542703905126007408259381,05000000015015030030030000087368417466514555595635675706730764796830840000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,811
2,698
2,688
938
739
727
671
200
176
160
138
183
150
119
95
37
37
30
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000028303737951191501831381601762006717277399382,6882,6982,81100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
24,600
0
0
0
23,700
0
0
0
19,300
0
0
0
15,100
14,300
12,800
11,400
12,700
11,800
9,900
7,700
1,100
700
33,700
33,800
33,000
33,400
33,800
34,200
32,300
41,000
44,600
44,500
51,200
70,000
70,600
71,900
61,100
62,300
63,800
64,300
55,300
60,400
62,100
63,000
64,000
64,700
65,300
66,300
68,800
69,500
70,900
72,700
75,600
78,300
81,700
84,678
87,176
89,270
91,236
93,574
97,517
99,375
100,231
102,747
104,733
108,444
109,890
111,123
109,380
109,294
108,382
108,204
104,166
111,233
110,979
110,093
108,267
105,453
102,018
99,384
95,587
94,799
133,592
144,556
141,894
141,441
138,019
136,993
138,289
131,124
123,275
119,595
119,595
116,180
105,480
102,040
97,016
96,925
91,850
91,647
88,715
83,472
78,841
76,409
49,101
45,712
40,290
35,422
34,132
33,094
32,190
37,923
36,950
36,113
34,862
34,060
42,606
47,213
54,447
52,968
89,554
88,491
87,728
88,562
88,872
89,182
87,959
86,379
81,121
75,670
67,497
90,999
86,028
78,328
70,860
62,330
58,381
59,018
61,789
64,967
68,586
66,760
65,126
62,187
54,462
44,990
32,830
18,928
78,462
78,462
70,775
70,77578,46278,46218,92832,83044,99054,46262,18765,12666,76068,58664,96761,78959,01858,38162,33070,86078,32886,02890,99967,49775,67081,12186,37987,95989,18288,87288,56287,72888,49189,55452,96854,44747,21342,60634,06034,86236,11336,95037,92332,19033,09434,13235,42240,29045,71249,10176,40978,84183,47288,71591,64791,85096,92597,016102,040105,480116,180119,595119,595123,275131,124138,289136,993138,019141,441141,894144,556133,59294,79995,58799,384102,018105,453108,267110,093110,979111,233104,166108,204108,382109,294109,380111,123109,890108,444104,733102,747100,23199,37597,51793,57491,23689,27087,17684,67881,70078,30075,60072,70070,90069,50068,80066,30065,30064,70064,00063,00062,10060,40055,30064,30063,80062,30061,10071,90070,60070,00051,20044,50044,60041,00032,30034,20033,80033,40033,00033,80033,7007001,1007,7009,90011,80012,70011,40012,80014,30015,10000019,30000023,70000024,600000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
300
300
255
256
256
269
270
271
271
284
284
285
285
285
285
300
300
300
308
309
324
325
325
325
328
328
328
328
329
362
373
372
373
376
376
380
383
384
384
384
386
387
388
388
388
389
390
390
390
391
391
395
395
396
397
406
413
424
439
443
448
454
461
461
461
461
463
463
463
463
464
465
470
471
472
472
472
472
476
476
476
476
479
479
479
482
485
485
485
485
487
487
487
487
496
499
499
504
5044994994964874874874874854854854854824794794794764764764764724724724724714704654644634634634634614614614614544484434394244134063973963953953913913903903903893883883883873863843843843833803763763733723733623293283283283283253253253243093083003003002852852852852842842712712702692562562553003002000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000-325,780-310,593-299,273-288,638-280,205-275,351-272,6960-273,645-275,651-277,953-278,252-274,927-265,0670-249,732-244,345-266,610-258,202-252,221-246,457-243,441-242,540-241,900-241,994-241,923-240,870-239,396-275,531-273,416-280,248-284,682-293,124-290,217-286,126-282,397-279,228-278,773-275,207-272,420-269,318-263,548-257,874-254,183-227,040-223,629-219,40800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-800
0
0
0
-1,000
0
0
0
-1,200
0
0
0
-1,500
-1,500
-1,500
-1,500
-1,900
-1,900
-1,900
-1,900
-2,400
-2,400
-2,400
-2,400
-3,100
-3,100
-3,100
-3,100
-3,100
-3,100
-3,100
-3,100
-3,200
-3,200
-3,200
-3,200
-3,900
-5,000
-5,200
-5,400
-4,700
-5,700
-5,900
-6,200
-5,400
-6,500
-6,600
-5,400
-6,000
-7,100
-7,100
-7,400
-6,600
-7,700
-7,900
-8,044
-7,329
-5,234
-5,234
0
-5,176
-5,176
-5,176
-5,176
-5,973
-5,973
-5,973
-5,973
-85
-128
-108
-146
-246
-264
-214
-121
-131
-153
-7,279
-7,279
-8,247
-8,247
-8,247
-142,000
42
152
338
518
1,586
49
-450
0
-188
1,167
536
705
875
1,579
1,895
2,881
3,793
2,831
2,203
2,368
1,605
1,765
1,857
1,818
1,858
1,814
1,767
1,746
1,744
1,852
1,887
1,867
1,861
1,923
2,149
1,927
2,199
2,453
2,437
2,321
2,013
2,096
1,518
1,847
2,100
2,370
2,172
2,378
2,580
2,309
2,226
2,510
1,681
1,852
1,270
1,268
1,352
1,629
1,971
2,882
3,151
3,884
2,529
2,157
0
1,878
2,046
2,0461,87802,1572,5293,8843,1512,8821,9711,6291,3521,2681,2701,8521,6812,5102,2262,3092,5802,3782,1722,3702,1001,8471,5182,0962,0132,3212,4372,4532,1991,9272,1491,9231,8611,8671,8871,8521,7441,7461,7671,8141,8581,8181,8571,7651,6052,3682,2032,8313,7932,8811,8951,5798757055361,167-1880-450491,58651833815242-142,000-8,247-8,247-8,247-7,279-7,279-153-131-121-214-264-246-146-108-128-85-5,973-5,973-5,973-5,973-5,176-5,176-5,176-5,1760-5,234-5,234-7,329-8,044-7,900-7,700-6,600-7,400-7,100-7,100-6,000-5,400-6,600-6,500-5,400-6,200-5,900-5,700-4,700-5,400-5,200-5,000-3,900-3,200-3,200-3,200-3,200-3,100-3,100-3,100-3,100-3,100-3,100-3,100-3,100-2,400-2,400-2,400-2,400-1,900-1,900-1,900-1,900-1,500-1,500-1,500-1,500000-1,200000-1,000000-800000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
306,046
306,263
303,764
304,358
304,500
304,659
302,525
304,288
306,074
308,772
314,966
317,160
319,939
322,738
324,856
324,966
325,077
325,253
326,109
326,288
326,445
326,751
327,771
328,294
329,971
330,425
330,517
330,770
331,030
331,463
332,490
332,704
332,923
333,225
334,268
334,473
334,640
335,688
336,859
337,126
337,342
338,021
339,023
339,462
339,892
340,407
342,055
344,435
0
0
00344,435342,055340,407339,892339,462339,023338,021337,342337,126336,859335,688334,640334,473334,268333,225332,923332,704332,490331,463331,030330,770330,517330,425329,971328,294327,771326,751326,445326,288326,109325,253325,077324,966324,856322,738319,939317,160314,966308,772306,074304,288302,525304,659304,500304,358303,764306,263306,04600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000-1,014-815000000000000000000-3,074-3,074-3,074-3,074-6,387-6,387-6,387-6,387-8,854-8,854-8,854-8,854-10,440-10,440-10,440-12,457-12,457-12,457-11,331-11,331-11,331-8,989-8,915-8,915-8,686-8,499-8,499-8,428-8,428-8,428-5,994-5,994-5,994-5,669-5,669-5,66900000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
21,000
0
0
0
21,900
0
0
0
20,800
0
0
0
21,000
21,000
21,000
21,000
21,500
21,500
21,500
21,500
22,000
22,000
54,100
54,100
55,200
55,200
55,500
56,400
61,400
69,500
73,500
73,500
75,100
75,200
75,200
76,300
85,700
87,100
88,200
88,500
88,400
94,400
96,100
96,700
96,400
97,600
97,800
46,700
98,400
99,500
99,500
100,000
99,100
101,200
103,300
104,481
104,679
103,004
135,666
130,908
138,312
138,345
165,353
165,414
166,473
166,495
166,495
166,495
199,082
199,361
199,884
200,197
200,251
224,263
224,487
225,005
224,649
225,141
233,271
234,070
235,750
236,207
279,819
428,357
286,984
288,025
288,472
289,373
292,480
293,219
293,540
0
293,841
296,162
296,420
297,388
297,707
298,034
298,353
299,267
299,446
299,659
299,876
300,690
301,284
301,426
301,585
302,525
302,889
306,074
308,772
314,966
318,904
319,939
322,738
324,856
326,827
325,077
325,253
326,109
328,487
326,445
326,751
327,771
330,307
329,156
329,411
330,517
332,870
331,030
331,463
332,490
335,284
332,923
333,225
334,268
334,473
334,640
335,688
336,859
337,126
337,342
338,021
339,023
339,462
339,892
340,407
342,055
1,878
344,435
346,252
346,252344,4351,878342,055340,407339,892339,462339,023338,021337,342337,126336,859335,688334,640334,473334,268333,225332,923335,284332,490331,463331,030332,870330,517329,411329,156330,307327,771326,751326,445328,487326,109325,253325,077326,827324,856322,738319,939318,904314,966308,772306,074302,889302,525301,585301,426301,284300,690299,876299,659299,446299,267298,353298,034297,707297,388296,420296,162293,8410293,540293,219292,480289,373288,472288,025286,984428,357279,819236,207235,750234,070233,271225,141224,649225,005224,487224,263200,251200,197199,884199,361199,082166,495166,495166,495166,473165,414165,353138,345138,312130,908135,666103,004104,679104,481103,300101,20099,100100,00099,50099,50098,40046,70097,80097,60096,40096,70096,10094,40088,40088,50088,20087,10085,70076,30075,20075,20075,10073,50073,50069,50061,40056,40055,50055,20055,20054,10054,10022,00022,00021,50021,50021,50021,50021,00021,00021,00021,00000020,80000021,90000021,000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-07-31)

Gross Profit (+$)
totalRevenue31,061
Cost of Revenue-19,495
Gross Profit11,56611,566
 
Operating Income (+$)
Gross Profit11,566
Operating Expense-31,106
Operating Income-24,736-19,540
 
Operating Expense (+$)
Research Development3,904
Selling General Administrative27,202
Selling And Marketing Expenses345
Operating Expense31,10631,451
 
Net Interest Income (+$)
Interest Income158
Interest Expense-0
Other Finance Cost-1,280
Net Interest Income-1,122
 
Pretax Income (+$)
Operating Income-24,736
Net Interest Income-1,122
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,022-20,376
EBIT - interestExpense = -14,800
32,587
20,288
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-14,800-25,022
Earnings Before Interest and Taxes (EBITDA)-12,118
 
After tax Income (+$)
Income Before Tax-25,022
Tax Provision-0
Net Income From Continuing Ops-25,022-25,022
Net Income20,288
Net Income Applicable To Common Shares20,288
 
Non-recurring Events
Discontinued Operations45,310
Extraordinary Items45,310
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses50,601
Total Other Income/Expenses Net-4,3601,122
 

Technical Analysis of Enzo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Enzo. The general trend of Enzo is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Enzo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Enzo Biochem Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.16 < 1.19 < 1.19.

The bearish price targets are: 1.

Tweet this
Enzo Biochem Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Enzo Biochem Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Enzo Biochem Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Enzo Biochem Inc. The current macd is -0.04126927.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enzo price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Enzo. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Enzo price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Enzo Biochem Inc Daily Moving Average Convergence/Divergence (MACD) ChartEnzo Biochem Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Enzo Biochem Inc. The current adx is 35.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Enzo shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Enzo Biochem Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Enzo Biochem Inc. The current sar is 1.23910721.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Enzo Biochem Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Enzo Biochem Inc. The current rsi is 24.68. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Enzo Biochem Inc Daily Relative Strength Index (RSI) ChartEnzo Biochem Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Enzo Biochem Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enzo price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Enzo Biochem Inc Daily Stochastic Oscillator ChartEnzo Biochem Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Enzo Biochem Inc. The current cci is -168.76061121.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Enzo Biochem Inc Daily Commodity Channel Index (CCI) ChartEnzo Biochem Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Enzo Biochem Inc. The current cmo is -66.14457128.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Enzo Biochem Inc Daily Chande Momentum Oscillator (CMO) ChartEnzo Biochem Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Enzo Biochem Inc. The current willr is -91.30434783.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Enzo Biochem Inc Daily Williams %R ChartEnzo Biochem Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Enzo Biochem Inc.

Enzo Biochem Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Enzo Biochem Inc. The current atr is 0.05343661.

Enzo Biochem Inc Daily Average True Range (ATR) ChartEnzo Biochem Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Enzo Biochem Inc. The current obv is 35,203,087.

Enzo Biochem Inc Daily On-Balance Volume (OBV) ChartEnzo Biochem Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Enzo Biochem Inc. The current mfi is 11.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Enzo Biochem Inc Daily Money Flow Index (MFI) ChartEnzo Biochem Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Enzo Biochem Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Enzo Biochem Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Enzo Biochem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.679
Ma 20Greater thanMa 501.213
Ma 50Greater thanMa 1001.274
Ma 100Greater thanMa 2001.298
OpenGreater thanClose1.110
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Enzo with someone you think should read this too:
  • Are you bullish or bearish on Enzo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Enzo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Enzo Biochem Inc

I send you an email if I find something interesting about Enzo Biochem Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Enzo Biochem Inc.

Receive notifications about Enzo Biochem Inc in your mailbox!